Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 May 2022 | Story Leonie Bolleurs | Photo Supplied
Dr maria Madiope and and Dr Justina Dugbazah
Dr Marinkie Madiope, the Campus Principal of the South Campus, recently received an award from Dr Justina Dugbazah (right), the Senior Programme Education and Social Development Coordinator of the African Union Panel on Emerging Technologies.

Dr Marinkie Madiope, the Campus Principal of the University of the Free State (UFS) South Campus, recently received an award from Dr Justina Dugbazah, the Senior Programme Education and Social Development Coordinator of the African Union Panel on Emerging Technologies’ Calestus Juma Executive Dialogue (APET-CJED) programme

Dr Madiope was recognised for the work she is doing in Africa through the CJED. She collected the award during CJED’s 6th Dialogue, in the presence of more than 20 African member states. 

Fit-for-purpose policies and curricula

The focus of this event, which took place in Dakar, Senegal, was on effectively harnessing educational innovations and technologies for formal and non-formal teaching and learning in Africa.

During the dialogue, the UFS was also appreciated for its visibility and impact on the African continent and was recognised as a prospective partner and collaborator on different science, technology, engineering, and mathematics (STEM) projects, which will be discussed and confirmed later in May 2022.

Dr Madiope, the Vice-President of the Technical Working Group (TWG) of the CJED, also gave a presentation at the dialogue, speaking about the education policy implementation curriculum review in Africa. Speaking from a South African context, she highlighted the different education policies and shared her views on how the relevant role players on the continent can collaborate to ensure that policies and curricula are designed and developed fit for purpose. 

Some of the recommendations were to contextualise education, science, technology and innovation policies, and teaching methods to the African context, and have science subjects translated into local languages for easy understanding and interpretation. It was also recommended to incentivise STEM education as to encourage girl participation in STEM projects. 

In the discussion following the dialogue presentation, member states also recommended that the funding set aside for education be increased to 25% of countries’ national budget.

Supporting the development of scarce skills

With AUDA-NEPAD’s support for skills development programmes that promotes the occupational prospects of young Africans, Dr Madiope’s presentation, which highlighted some of the scarce skills on the continent, was welcomed. According to her, the Media, Information and Communication Technologies Sector Education and Training Authority (MICTSETA) has identified a number of scarce skills on the continent. These skills, aligning with the Fourth Industrial Revolution, include artificial intelligence, cybersecurity, cloud computing, data science, software development, internet of things, robotic processing automation, design thinking, and quality engineering. The university are planning to get involved in developing the skills of the youth on the African continent in terms of three-dimensional printing, drone manufacturing, and drone awareness.

• CJED is supported by APET, the African Union Development Agency, and the New Partnership for Africa’s Development (AUDA-NEPAD) strategic initiative. APET advises the African Union and member states on harnessing emerging technologies for economic development, and AUDA-NEPAD provides a platform to promote inter-country and inter-regional learning and knowledge exchange on science, innovation, and emerging technologies across Africa.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept